Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infection in Patients With Obesity or Diabetes: A Subgroup Analysis of Pooled Phase 3 Clinical Trials.
Autorzy:
Riccobene T; AbbVie Inc., Madison, New Jersey, USA. Lock J; AbbVie Inc., Madison, New Jersey, USA. Lyles RD; AbbVie Inc., Madison, New Jersey, USA. Georgiades B; AbbVie Inc., Madison, New Jersey, USA. Nowak M; AbbVie Inc., Madison, New Jersey, USA. GonzalezPL; AbbVie Inc., Madison, New Jersey, USA. Park J; AbbVie Inc., Madison, New Jersey, USA. Rappo U; AbbVie Inc., Madison, New Jersey, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2023 May 09; Vol. 10 (6), pp. ofad256. Date of Electronic Publication: 2023 May 09 (Print Publication: 2023).
Impact of Underlying Comorbidities on Outcomes of Patients Treated with Ceftaroline Fosamil for Complicated Skin and Soft Tissue Infections: Pooled Results from Three Phase III Randomized Clinical Trials.
Autorzy:
Wilcox M; Department of Microbiology, Leeds Teaching Hospitals, University of Leeds, Leeds, LS1 3EX, UK. . Yan JL; Pfizer, New York, NY, USA. GonzalezPL; AbbVie, Madison, NJ, USA. Dryden M; Royal Hampshire County Hospital, Winchester, UK. Stone GG; Pfizer, Groton, CT, USA. Kantecki M; Pfizer, Paris, France.
Pokaż więcej
Źródło:
Infectious diseases and therapy [Infect Dis Ther] 2022 Feb; Vol. 11 (1), pp. 217-230. Date of Electronic Publication: 2021 Nov 06.
Safety of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Nephrotoxicity Rates Compared with Vancomycin: A Post Hoc Analysis of Three Clinical Trials.
Autorzy:
GonzalezPL; AbbVie, Madison, NJ, USA. . Rappo U; AbbVie, Madison, NJ, USA. Mas Casullo V; AbbVie, Madison, NJ, USA. Akinapelli K; Independent Consultant, Hamden, CT, USA. McGregor JS; AbbVie, Madison, NJ, USA. Nelson J; AbbVie, Madison, NJ, USA. Nowak M; AbbVie, Madison, NJ, USA. Puttagunta S; Iterum Therapeutics, Old Saybrook, CT, USA. Dunne MW; Iterum Therapeutics, Old Saybrook, CT, USA.
Pokaż więcej
Źródło:
Infectious diseases and therapy [Infect Dis Ther] 2021 Mar; Vol. 10 (1), pp. 471-481. Date of Electronic Publication: 2021 Jan 30.
Sanchez-GonzalezPL; Escuela Técnica Superior de Ingenieros Navales, Universidad Politécnica de Madrid (UPM). Av. Arco de la Victoria, 4, 28040 Madrid, Spain. pl.. Díaz-Gutiérrez D; Escuela Técnica Superior de Ingenieros Navales, Universidad Politécnica de Madrid (UPM). Av. Arco de la Victoria, 4, 28040 Madrid, Spain. . Leo TJ; Escuela Técnica Superior de Ingenieros Navales, Universidad Politécnica de Madrid (UPM). Av. Arco de la Victoria, 4, 28040 Madrid, Spain. . Núñez-Rivas LR; Escuela Técnica Superior de Ingenieros Navales, Universidad Politécnica de Madrid (UPM). Av. Arco de la Victoria, 4, 28040 Madrid, Spain. .
Pokaż więcej
Źródło:
Sensors (Basel, Switzerland) [Sensors (Basel)] 2019 Feb 22; Vol. 19 (4). Date of Electronic Publication: 2019 Feb 22.
Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety.
Autorzy:
Rappo U; Clinical Development, Allergan plc, Madison, New Jersey. Puttagunta S; Clinical Development, Allergan plc, Madison, New Jersey. Shevchenko V; Orthopedic and Trauma Department, Cherkasy Regional Hospital, Cherkasy, Ukraine. Shevchenko A; Orthopedic and Trauma Department, Cherkasy Regional Hospital, Cherkasy, Ukraine. Jandourek A; Clinical Development, Allergan plc, Madison, New Jersey. GonzalezPL; Medical Affairs, Allergan plc, Jersey City, New Jersey. Suen A; Clinical Development, Allergan plc, Madison, New Jersey. Mas Casullo V; Clinical Development, Allergan plc, Madison, New Jersey. Melnick D; Clinical Development, Allergan plc, Madison, New Jersey. Miceli R; Clinical Development, Allergan plc, Madison, New Jersey. Kovacevic M; Clinical Development, Allergan plc, Madison, New Jersey. De Bock G; Clinical Development, Allergan plc, Madison, New Jersey. Dunne MW; Clinical Development, Allergan plc, Madison, New Jersey.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2018 Dec 10; Vol. 6 (1), pp. ofy331. Date of Electronic Publication: 2018 Dec 10 (Print Publication: 2019).
Competition for Materno-Fetal Resource Partitioning in a Rabbit Model of Undernourished Pregnancy.
Autorzy:
Lopez-Tello J; Department of Animal Production, Veterinary Faculty, Complutense University of Madrid, Ciudad Universitaria, Madrid, Spain. Arias-Alvarez M; Department of Animal Production, Veterinary Faculty, Complutense University of Madrid, Ciudad Universitaria, Madrid, Spain. Jimenez-Martinez MA; Department of Animal Medicine and Surgery, Veterinary Faculty, Complutense University of Madrid, Ciudad Universitaria, Madrid, Spain. Garcia-Garcia RM; Department of Physiology (Animal Physiology), Veterinary Faculty, Complutense University of Madrid, Ciudad Universitaria, Madrid, Spain. Rodriguez M; Department of Agrarian Production, E.T.S.I.A.A.B. Polytechnic University of Madrid, Ciudad Universitaria, Madrid, Spain. Lorenzo GonzalezPL; Department of Physiology (Animal Physiology), Veterinary Faculty, Complutense University of Madrid, Ciudad Universitaria, Madrid, Spain. Bermejo-Poza R; Department of Animal Production, Veterinary Faculty, Complutense University of Madrid, Ciudad Universitaria, Madrid, Spain. Gonzalez-Bulnes A; Comparative Physiology Group, SGIT-INIA, Avda. Puerta de Hierro, Madrid, Spain. Garcia Rebollar P; Department of Agrarian Production, E.T.S.I.A.A.B. Polytechnic University of Madrid, Ciudad Universitaria, Madrid, Spain.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2017 Jan 03; Vol. 12 (1), pp. e0169194. Date of Electronic Publication: 2017 Jan 03 (Print Publication: 2017).
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
